High diagnostic yield of targeted next-generation sequencing panel as a first-tier molecular test for the patients with myopathy or muscular dystrophy. (2023)
Attributed to:
MRC Strategic Award to establish an International Centre for Genomic Medicine in Neuromuscular Diseases
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/ahg.12492
PubMed Identifier: 36575883
Publication URI: http://europepmc.org/abstract/MED/36575883
Type: Journal Article/Review
Volume: 87
Parent Publication: Annals of human genetics
Issue: 3
ISSN: 0003-4800